Successful engraftment of neural stem cells (NSCs) following implantation into the brains of rodent models has demonstrated the potential of neural stem cells in the development of regenerative therapeutic strategies. Specifically, the discovery that neurons, astrocytes and oligodendrocytes arise from neural stem cells has created new opportunities for treating CNS diseases. Merck offers antibodies for neuronal stem cells, to targets such as: Nestin, CD133, bIII Tubulin, GFAP, Sox-2, Ki-67, PCNA, MPM-2, and many more.
